Marike Gabrielson

The paper assesses breast cancer risks linked to rare missense variants in five susceptibility genes using logistic and mixture models, finding varying risk contributions across genes.

The paper identifies a proteomic signature associated with menopausal hormonal therapy use and increased breast cancer risk using a data-driven analysis of plasma proteins.

The paper analyzes rare copy number variants (CNVs) in breast cancer cases and controls, identifying associations with known and novel susceptibility loci.